Increased repression of mRNAs involved in “negative regulation of interleukin-1-mediated signalling pathway” implies potential increased IL-1 signalling at CT + 7 in the placebo group 7 days into infection compared with ChAdOx1 nCoV-19 vaccinees. This evidence concerns the gene IL1B and infection.